Skip to Content

Participate in Research

Here is an opportunity to support the research process. Please consider participating in the following research projects

Latest Projects

Title
A herbal complex for sleep quality, mood and cognitive function: Randomised Clinical Trial
Contact
Sarah Benson sbenson@swin.edu.au
Description

The Centre for Human Psychopharmacology is currently investigating the effects of 2 weeks supplementation with a herbal sleep formula on overall sleep quality, stress, mood and cognitive function.

You may be eligible if you:

  • Have been experiencing sleep difficulties for over 1 month
  • Are aged 25-50 years
  • Have BMI 18-30 kg/m2
  • Are in good general health with no significant diagnosed diseases
  • Have a typical bedtime between 9pm-12pm
  • Are not taking any medications or supplements for sleeping
  • Do not smoke more than 10 cigarettes per day

*Please note there will be further inclusion criteria to participate in the study

Participation will require you to attend the Centre for Human Psychopharmacology on 4 separate occasions (one screening visit and 3 testing visits), spanning over a 1 month period. At testing visits you will be asked to complete a number of questionnaires relating to your mood and sleeping patterns, in addition to completing a computerised cognitive test battery.

You will be randomly assigned to placebo or treatment condition, and will be asked to take a daily supplement for 3 weeks. To measure any changes in sleep quality, you will be required to complete a daily online sleep diary, and on specific days, a number of other online questionnaires.

If you, or someone you know, may be interested in taking part in this clinical trial and would like further information, please contact:
Sarah Benson at the Centre for Human Psychopharmacology, Hawthorn.
Phone: (03) 9214 4506
Email: sarahbenson@swin.edu.au

Title
Effects of theanine on stress and brain activity
Contact
David White dawhite@swin.edu.au
Description

The Centre for Human Psychopharmacology is currently investigating the effects L-theanine (an amino acid found primarily in green tea) on stress, mood, cognitive function and brain activity. Evidence from previous studies suggests L-theanine may promote relaxation and reduce stress and anxiety.

You may be eligible if you:

  • aged 18-40
  • in good physical health & free from major diseases
  • non-smoker
  • not pregnant or lactating
  • right handed

Participation involves 3 visits to Swinburne University in Hawthorn, consisting of cognitive and mood tests, brain imaging and providing saliva samples. The first visit involves confirming eligibility, practicing cognitive tasks, and undergoing a structural scan of your brain using MRI. The following two sessions will take up to 5.5 hours, where you will be asked to consume a beverage containing L-theanine or a placebo. You will be compensated $150 at the end of the trial.


If you or someone you know may be interested in taking part in this clinical trial and would like further information, please contact:
David White at the Centre for Human Psychopharmacology, Hawthorn.
Phone: (03) 9214 5341
Email: dawhite@swin.edu.au

Title
Healthy Body Vitamin Pack: Randomised Clinical Trial
Contact
Chantelle Schokman cschokman@swin.edu.au
Description

Improving objective and subjective measures of workplace stress in a healthy adult population

The Centre for Human Psychopharmacology at Swinburne University of Technology is currently investigating the effects of Cooper's Complete Healthy Body Vitamin Pack supplementation on workplace stress and other quality of life aspects

You may be eligible if you:

  • Are aged 30-65 years.
  • Are in good general health with no history of psychiatric disease.
  • Are in full-time employment
  • Have corrected to normal vision.
  • Are not pregnant or lactating.
  • Report sometimes feeling stressed in the workplace.

You will also be compensated for your time and travel expenses.

Participation involves taking Multivitamin and Omega 3 fish oil supplements or a placebo for 3 months. Participants are required to attend Swinburne University on 2 separate occasions, 3 months apart for approx. 2 - 2 ½ hours each. Testing will involve having blood taken, cognitive testing and completing a series of health and mood questionnaires. In addition, every four weeks participants complete an online questionnaire which takes approx. 30-45 minutes.

If you or someone you know may be interested in taking part in this clinical trial and would like further information or a consent form, please contact:
Chantelle Schokman at the Centre for Human Psychopharmacology, Hawthorn.
Phone: (03) 9214 4924
Email: cschokman@swin.edu.au

Title:
Executive B and Stress: Randomised Clinical Trial
Description:

Improving objective and subjective measures of workplace stress in a healthy adult population.

The Centre for Human Psychopharmacology is currently investigating t he effects of Blackmore's Executive B Stress Formula on workplace stress, mood and cognition. They are seeking people who are willing to participate in this research.

You may be eligible if you:

  • Are aged 30-65 years
  • Are in good general health with no history of psychiatric disease
  • Are in full-time employment
  • Have corrected to normal vision
  • Are not pregnant or lactating
  • Report sometimes feeling stressed in the workplace

You will also be compensated for your time and travel expenses.

Participation involves taking Blackmore's Executive B Stress Formula or a placebo for 6 months. Participants are required to attend Swinburne University on 2 separate occasions, 6 months apart for approx 2.5 - 3.5 hours each. Testing will involve having blood taken, cognitive testing and completing a series of health and mood questionnaires. Some participants will also have the option to undergo brain imaging also. In addition, every four weeks participants complete an online questionnaire which takes approx 30-45 minutes.

If you or someone you know may be interested in taking part in this clinical trial and would like further information or a consent form, please contact Clare Billings at the Centre for Human Psychopharmacology, Hawthorn. Phone: (03) 9214 8229 email: cbillings@swin.edu.au.

Title:
An investigation into the cognitive effects and bioavailability of components of green tea
Description:

The Centre for Human Psychopharmacology is currently investigating the effects of green tea and combinations of its ingredients (caffeine and catechins) on cognitive function and mood. They are seeking people who are willing to participate in this research.

You may be eligible if you:

  • Are aged 18-40 years.
  • Are in good general health with no history of psychiatric disease.
  • Are a regular caffeine consumer (between 1-4 cups of coffee per day most days or the caffeine equivalent).
  • Have corrected to normal vision.
  • Are not pregnant or lactating.

You will also be compensated with $200 at the end of the trial.

Participation will involve attending Swinburne University in Hawthorn on 6 separate occasions. One session will be a practice session which will run for 1.5 hours. Subsequent testing sessions will run for approximately 4.5 hours. You will consume variants of Green Tea extract or placebo during each testing session.

If you or someone you know may be interested in taking part in this clinical trial and would like further information, please contact Naomi Perry or Sarah Benson at the Centre for Human Psychopharmacology, Hawthorn. Phone: 9214 8268 or 9214 4506 or email: swingreentea@gmail.com.

Title:
Social Anxiety in a "Connected" World
Description:

Researchers at Swinburne are investigating the use of computer mediated communication such as Facebook, Instant Messenger, Email, Forums etc. by people who find social interaction challenging.

With the advent of internet based technology, a growing number of devices can now be used to communicate with other people. Communication via the internet varies in complexity from text based email and forums, to video enhanced instant chat rooms. This type of communication has been termed Computer Mediated Communication or CMC.

This study will explore what this trend might mean for individuals who have identified that they experience symptoms that are commonly associated with social anxiety. Typically experienced in social situations, these symptoms might include features such as a blushing, a racing heart and sweating, thoughts that others are thinking negative thoughts about them, or that they appear stupid and can lead the individual to use a variety of strategies to avoid social experiences. The study will explore why these individuals might use computer technology for communication, what they expect to get from the experience and the extent to which the experience meets their expectations.

We want to talk to people who are:

  • 18 or over
  • Like to use online communication
  • Feel quite anxious in a social situation


We will ask you some questions about how and why you use the computer to communicate with others, and about how you may feel in social situations.

Participation involves an interview with the researcher that will take approximately 1.5 hours. This can be done at a convenient location (eg: Swinburne University library, local cafe etc.), or by phone or other online method such as Skype or Face-time.

Further information can be found at:

web: http://www.users.on.net/~ianclark/Index.html
email: iclark@swin.edu.au

Title:
ARC-LI Study
Description:

The Centre for Human Psychopharmacology (CHP) is conducting the Australian Research Council-funded Longevity Investigation (ARC-LI) We are seeking people who are willing to participate in this research.

You may be eligible if you:

  • Are aged between 60 - 75
  • Do not smoke
  • In good general health
  • Are not taking certain medications (further criteria applies)

Participation involves 5 visits of 2 -3 hours to the Centre for Human Psychopharmacology at Swinburne University (Hawthorn)while taking a daily supplement over a 52 week period. This study will utilise computerised cognitive tools, cardiovascular measures and markers from blood samples.

If you would like further information or to be involved please contact the ARCLI team on 9214 8267 or 9214 5472 or email arcli@swin.edu.au

Title:
Age, Balance And Thinking
Description:

This fourth year psychophysiology project aims to investigate the relationship between balance and cognitive performance for females aged between 45 and 60 years.

Specifically this study will be looking at how balance and cognition affect each other, how this might be related to a person's attention abilities and whether this has any relationship to core strength.

Participants must be female, 45-60 and if you have not suffered any clinically significant balance, vestibular, psychiatric, neurological conditions within the past 12 months, you could be eligible to participate in this study.

The study will take approximately 1 hour.

If you are interested in participating in this 1 hour study, please email: cogbalance@swin.edu.au

Title:
Can the use of multivitamins improve brain function?
Description:

Researchers at Swinburne are looking for pariticpants to take part in a study investigating the effects of multivitamins on mood, stress and brain function.

To be eligible you need to be:

  • Aged over 50 years, right-handed and a non-smoker
  • Not currently taking a multivitamin or herbal supplement
  • Not taking anti-depressant or blood thinning medications
  • Able to attend two sessions at Swinburne's Hawthorn campus

You will be compensated $70 for your participation.

For further information, please contact Renee on:

Phone: (03) 9214 5656 or

Email: rrowsell@swin.edu.au

Title:
Inflammation in Major Depressive Disorder.
Description:

Researchers at Swinburne's new neuro-imaging facility are examining the role inflammation plays in depressive symptoms. The study is looking for healthy control participants and those with a diagnosis of Major Depressive Disorder to take part.

The study takes place over 3 testing sessions at least one week apart - one session examining brain activation and chemical makeup using a Magnetic Resonance Imaging (MRI), one recording brain electromagnetic activity with an Magnetoencephalogram (MEG) to emotional faces, and a final session where a blood sample is taken and a cognitive test examining areas such as memory and attention is given.

If you'd like to participate, there are some criteria that you need to meet:

For people with depression:

  • Aged 18 - 60
  • A current diagnosis of Major Depressive Disorder / Major Depressive Disorder Recurrent with at least two lifetime episodes
  • Currently in the acute phase of the illness (having a depressed episode)
  • No sub-category diagnosis (Psychotic, Melancholic, Catatonic etc)
  • No co-morbid mental disorder (Bi-polar, Schizophrenia, PTSD etc)
  • Currently seeing a treating mental health professional (Psychiatrist / GP / Psychologist) who can verify the diagnosis.

For controls:

  • Aged 18 - 60
  • No diagnosis of any mental illness
  • Do not score above a "Moderate" score on the Depression Stress Anxiety Scale.

Both groups:

  • Not pregnant or breastfeeding
  • No history of alcohol or drug abuse
  • No head trauma leading to loss of consciousness for more than 10 minutes
  • No known neurological disorders / illnesses
  • Not taking anti-inflammatory medications
  • Have not been physically ill within the last one (1) month (cold, flu etc)
  • Willing to have blood taken
  • No metallic implants (especially pacemakers or neurostimulators) or history of working around metal fragments (welding etc)

If this is something you’d like to take part in OR you may know someone who may want to participate, please email
Peter Goodin (Swinburne University of Technology)
Email: pgoodin@swin.edu.au